LAKHESYS
LIVE

Serial Number

79412703

Owner

ASTRAVEUS

Attorney

H. David Starr

Filing Date

Aug 28, 2024

Add to watchlist:

No watchlists yet
View on USPTO

LAKHESYS Trademark

Serial Number: 79412703 • Registration: 8200213

LAKHESYS is a trademark filed by ASTRAVEUS on August 28, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

ASTRAVEUS (4 trademarks)

1 avenue Claude Vellefaux - Hôpital Saint-Louis

Entity Type: 34

Trademark Details

Filing Date

August 28, 2024

Registration Date

April 7, 2026

Published for Opposition

February 17, 2026

Goods & Services

Medical services for biological and cell analysis and manipulation for medical use; medical and health services in biology, namely, provision of health care and medical services by health care professionals; culturing and manufacturing cells for medical therapy purposes, namely, medical treatment of cancer using cultured cells; biological and cell therapy services; medical services for therapy by means of integrated microfluidic bioproduction; information services with respect to biological and cell medical therapies

Biological laboratory services; design, development, installation, maintenance and rental of laboratory apparatus and instruments, namely, microfluidic cell production units, microfluidic bioprocessors and microfluidic cartridges; bioproduction services, namely, biochemical development; culturing and manufacturing cells for scientific research purposes; scientific research in the field of biology, and integrated microfluidic bio-production; biological and cell analysis and manipulation services for scientific use; scientific analysis and retrieval of data in the fields of biology and integrated microfluidic bio-production; computer platform as a service (PaaS) featuring software for cell analysis and manufacturing in the field of biology; design, development, installation, rental and maintenance of computer software in the field of bioproduction and cell production; software as a service (SaaS) featuring software for cell analysis and manufacturing in the field of biology; information services with respect to scientific research by conducting clinical trials

Scientific apparatus and instruments for analysis, control and detection of biological and cellular material, namely, combination apparatus consisting of microscopes, spectrometers for laboratory use and microfluidic bioprocessors for laboratory use; microfluidic chips; programmable microfluidic chips; downloadable chemical, biological and cellular analysis software for cell manufacturing; downloadable chemical, biological and cellular database software for cell manufacturing; scientific and laboratory apparatus for pharmaceutical production and bioproduction, namely cell culture incubators for scientific use, bioreactors for cell culturing, and cell culturing vessels for laboratory use; bioreactors for laboratories; laboratory chemical reactors for pharmaceutical production

Medical diagnostic apparatus and instruments for biological and cell analyses; medical diagnostic apparatus and instruments for the detection, analysis and handling of genetic material; genomic analysis apparatus for medical use; medical apparatus and instruments for detecting, analyzing and manipulating biological and cell material for medical use

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 4, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 18, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 18, 2026 OPNR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 7, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 7, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 17, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 17, 2026 PUBO
NOTIFICATION PROCESSED BY IB
Feb 12, 2026 GPNX
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 11, 2026 NONP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 28, 2026 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 27, 2026 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 21, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 24, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 24, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Dec 24, 2025 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 5, 2025 GNFN
FINAL REFUSAL E-MAILED
Aug 5, 2025 GNFR
FINAL REFUSAL WRITTEN
Aug 5, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 8, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 7, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 7, 2025 TROA
REFUSAL PROCESSED BY IB
May 9, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 24, 2025 RFCS
REFUSAL PROCESSED BY MPU
Apr 24, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 14, 2025 RFCR
NON-FINAL ACTION WRITTEN
Mar 13, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 4, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 20, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 20, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 19, 2024 REPR